MerrillJ.P., MurrayJ.E., HarrisonJ.H., GuildW.R., 1984, Landmark Article Jan 28. 1956: “Successful Homotransplantation of the human Kidney Between Identical Twin,”JAMA251(19): 2566–71.
2.
MurrayJ.E., 1993, The Edward Jenner Lecture, “Biological Spinoffs of Organ Transplantation,”Ann NY Acad Sci685: 388–99.
3.
BorelJ.F.1996, “In Vivo Pharmacological Effects of Ciclosporin and Some Analogues,”Adv Pharmacol35: 115–246.
MurrayJ.E., 1992, “Human Organ Transplantation: Background and Consequences,”Science256: 1411–16.
6.
LambD., 1996, Organ Transplants and Ethics, Aldershot, Brookfield, USA, p. 123.
7.
CaplanA.L., 1995, “Transplantation. III. Ethical and Legal Issues,” In: ReichW.T., ed., Encyclopedia of Bioethics, Revised Edition, New York, NY: Simon and Schuster Macmillan, p. 1888–94.
8.
CaplanA.L., 1984, “Ethical and Policy Issues in the Procurement of Cadaver Organs for Transplantation,”New Engl J Med311: 981–83.
9.
MurrayJ.E., 1964, “Moral and Ethical Reflections on Human Organ Transplantation,”Linacre Quarterly31(2): 54–6.
10.
PellegrinoE.D., 1996, “Clinical Ethics: Balancing Praxis and Theory,”Kennedy Institute of Ethics Journal6(4): 347–51.
11.
ProttasJ., 1989, “The Organization of Organ Procurement,” in: BlumsteinJ.F., and SloanF.A., eds., Organ Transplant Policy: Issues and Prospects, Duke University Press, p. 41–55.
12.
HansmannH., 1989, “The Economics and Ethics of Markets for Human Organs,” in: BlumsteinJ.F., and SloanF.A., eds., Organ Transplant Policy: Issues and Prospects, Duke University Press, p. 57–85.
13.
CohenL.R., 1989, “Increasing the Supply of Transplantable Organs: The Virtues of a Futures Market,”George Washington Law Review58: 1–51.
14.
VeatchR.M., 1991, “Medical Ethics,” in: LandW., and DossetorJ.B., eds., Organ Replacement Therapy: Ethics, Justice, Commerce, Berlin: Springer-Verlag.
15.
LambD., 1996, Organ Transplants and Ethics, Aldershot, Brookfield, USA, p. 11.
16.
MuellerK.J., 1989, “Biomedical Technology and Public Policy.” In: BlankR.H., and MerrickJ.C., eds., Encyclopedia of US Biomedical Policy, New York, NY: Greenwood Press, p. 143–65.
17.
MuellerK.J., 1989, “Biomedical Technology and Public Policy.” In: BlankR.H., and MerrickJ.C., eds., Encyclopedia of US Biomedical Policy, New York, NY: Greenwood Press, p. 143–65.
18.
RatnerA.J., MichlerR.E., and RoseE.A., 1995, In: ReichW.T., ed., Encyclopedia of Bioethics, Revised Edition, New York, NY: Simon and Schuster Macmillan, p. 2593–97.
19.
Institute of Biology (Great Britain). “Xenotransplantation - Reply to the Government's Response from The Institute of Biology.” Downloaded from Internet Web site: http://www.thomson.com/job/xenotrans2.html on 16 Jan 1998.
20.
WeissR.A., 1998, “Transgenic Pigs and Virus Adaptation,”Nature391: 327–28.
21.
ButlerD., WadmanM., LehrmanS., and SchiermeierQ., 1998, “Last Chance to Stop and Think on Risks of Xenotransplant,”Nature391: 320–24.
22.
WadmanM., 1998, “FDA Turns Down Moratorium Demand on Xenotransplants,”Nature391: 423.
23.
JonasH., 1989, “Philosophical Reflections on Experimenting with Human Subjects.” In: FreundP.A., ed., Experimentation With Human Subjects, New York, NY: George Brazitler, p. 1–31.
24.
MurrayJ.E., LynchJ.J., 1967, “Ethical Implications of Renal Transplants,”JAMA200(2): 187.
25.
GearhartJ., 1998, “New Potential for Human Embryonic Stem Cells,”Science282: 1061–62.
26.
DoerflingerR., 1999, “Destructive Stem Cell Research on Human Embryos,”Origins28(45): 770–73.
27.
PellegrinoE.D., 1999, “Embryo Research: The Necessity for Moral Constraints,”Georgetown University Newspaper of June 7, 1999, p. 8.
28.
LambD., 1996, Organ Transplants and Ethics, Aldershot, Brookfield, USA.
29.
BernardinJ., 1988, Consistent Ethic of Life, FuechtmannT.G., ed., Sheed & Ward, Kansas City, MO.
30.
MeilaenderG., 1978, The Taste for the Other: The Social and Ethical Thought of C.S. Lewis, Erdmans, Grand Rapids, MI.